Canine Dilated Cardiomyopathy (DCM): Clinical Approach and New Perspectives

Webinar rating:
Published on: 20.02.2019


Nuala Summerfield, Founder and Director
BSc, BVM&S, MRCVS, DipACVIM (Cardiology), DipECVIM-CA (Cardiology)
RCVS, European and American Recognised Specialist in Veterinary Cardiology

Add to favorites

About The Webinar

Dilated cardiomyopathy (DCM) is a form of canine acquired heart disease that typically affects large and giant breeds of dog. DCM develops gradually, often over a period of years, before symptoms of congestive heart failure develop. This early, symptom-free stage of the disease, known as the preclinical phase, has recently received much attention as a key disease stage for therapeutic intervention. However, this highlights the importance of correct diagnosis of preclinical DCM, which unfortunately is not always straightforward.

At the end of this session, attendees should expect to:
• Be aware of the published clinical trial evidence to support medical treatment in preclinical DCM in Dobermanns and Irish Wolfhounds
• Be aware of ongoing studies evaluating the important question of treatment benefit in other breeds with preclinical DCM
• Be aware of the updated guidelines for diagnosis of preclinical DCM in the Dobermann
• Be aware of the breed variations in heart size that can potentially confuse the diagnosis of preclinical DCM

CPD/CE Tracker

When you have watched the webinar, click on the 'Add To Tracker' button below. This will add a record to your CPD Tracker dashboard located in the main menu under 'My Membership'. Complete the reflective learning fields for future reference. When you click 'update' the information is saved. You can edit this information at a later date either on the webinar page or in your CPD Tracker dashboard. We recommend you download your record regularly for safekeeping.